MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%
ChargePoint Holdings, Inc.
CHPT Details
ChargePoint Holdings, Inc. (NYSE: CHPT) develops, produces, and sells networked electric vehicle (EV) charging system infrastructure, as well as subscription-based cloud-based services that allow consumers to find, reserve, authenticate, and pay for EV charging sessions. In addition, the network provides a range of web-based interfaces for commercial, fleet, and residential users. CHPT earns money by selling Networked Charging Systems, Cloud Services, and extended parts and labor warranties, often paid for in advance.
Latest News
Q3FY22 Results
Key Risks
Outlook
Valuation Methodology: Price/Sales Per Share Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
CHPT Daily Technical Chart (Source: REFINITIV)
Stock Recommendation
CHPT's stock price fell 53.26% in the past twelve months and is currently leaning towards the lower band of its 52-week range of USD 17.60 to USD 49.48. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 32.18. We have valued the stock using the Price/Sales-based relative valuation methodology and arrived at a target price of USD 24.70.
Considering the significant correction in the stock price, strategic acquisitions, strong balance sheet, positive outlook, and associated risks, we recommend a "Speculative Buy" rating on the stock at the current price of USD 19.585, down 5.34% as of December 10, 2021, 11:36 AM ET.
* The reference data in this report has been partly sourced from REFINITIV.
* All forecasted figures and industry information have been taken from REFINITIV.
* Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.
ON24, Inc.
ONTF Details
ON24, Inc. (NYSE: ONTF) provides cloud-based digital experience platforms that help companies turn client engagement into revenue through interactive webinars, virtual events, and multimedia content experiences. Its platform's portfolio of content-rich digital experience products generates and captures actionable, real-time data at scale from millions of professionals every month, providing businesses with buying signals and behavioral insights to convert prospects into customers more efficiently.
Latest News:
9MFY21 Results:
Key Risks:
Outlook:
Valuation Methodology: EV/Sales Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
ONTF Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
ONTF's stock price has fallen 54.87% in the past six months and is currently close to the lower end of its 52-week range of USD 15.07 to USD 81.98. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 47.21. We have valued the stock using the EV/Sales-based relative valuation methodology and arrived at a target price of USD 21.08.
Considering the significant correction in the stock price, decent balance sheet, current valuation, and associated risks, we recommend a "Speculative Buy" rating on the stock at the current price of USD 16.68, down 1.24% as of December 10, 2021, 12:51 PM ET.
* The reference data in this report has been partly sourced from REFINITIV.
* All forecasted figures and industry information have been taken from REFINITIV.
*Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.
Agile Therapeutics, Inc.
AGRX Details
Agile Therapeutics, Inc. (NASDAQ: AGRX) is a women's healthcare firm whose mission is to meet women's unmet medical needs. Twirla (levonorgestrel and Ethinyl estradiol) transdermal system, the company's first product, is non-daily prescription contraception. Twirla is based on Skinfusion, a patented transdermal patch technology that allows medication delivery via the skin. As of December 10, 2021, its market capitalization stood at USD 81.70 million.
Latest News:
9MFY21 Results:
Key Risks:
Valuation Methodology: EV/Sales Multiple Based Relative Valuation
(Analysis by Kalkine Group)
* % Premium/(Discount) is based on our assessment of the Company's NTM trading multiple after considering its key growth drivers, economic moat, stock's historical trading multiples versus peer average/median, and investment risks.
AGRX Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
AGRX's stock price has declined 70.00% in the past nine months and is currently trading close to the lower-band of the 52-week range of USD 0.54 to USD 3.77. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is 46.69. We have valued the stock using the EV/Sales-based relative valuation methodology and arrived at a target price of USD 0.78.
Considering the significant correction in the stock price in the past nine months, its revenue-generating capabilities, current valuation, and associated risks, we recommend a "Speculative Buy" rating on the stock at the closing price of USD 0.6599, down 1.95% as of December 10, 2021.
* The reference data in this report has been partly sourced from REFINITIV.
* All forecasted figures and industry information have been taken from REFINITIV.
* Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.